Followers | 8 |
Posts | 656 |
Boards Moderated | 0 |
Alias Born | 04/24/2006 |
Monday, November 22, 2021 10:21:08 PM
U.S. Patent and Trademark Office Releases Regen Biopharma's Patent Application for Reduction of Post-Surgery Cancer Metastasis by Combination of Cannabidiol and NR2F6 Inhibition
PHARMACEUTICAL | Fri 19 Nov 2021Alexandria, Nov. 19 -- U.S. Patent and Trademark Office has released Regen Biopharma's patent application for reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition. Ichim Thomas and Koos David developed the invention. The patent application number is 17/037284. International Patent Cl..
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM